Company intelligence
EATRIS
Resources and services for research communities to translate scientific discoveries into patient benefit
About EATRIS
EATRIS is the European infrastructure for translational medicine. We bring together resources and services for research communities to translate scientific discoveries into benefits for patients. We provide access to a vast array of pre-clinical and clinical expertise and facilities that are available within 115+ top-tier academic centres across Europe. We focus on improving and optimising preclinical and early clinical development of drugs, vaccines and diagnostics, and overcome barriers to health innovation. Our research infrastructure offers a broad range of research services for both academia and industry across various research fields. In addition, we work with public funding agencies, charities and policy makers with tailored actions to help improve the translational research and innovation ecosystem.
Verified activity
Signals from EATRIS
8 published signals
Presence & Recognition
EATRIS Italy Spotlight Programme announced the 2026 A_IATRIS Young Researchers Award to recognize outstanding researchers under 40 from A_IATRIS Institutes contributing to strategic areas of translational medicine.
Reported by EATRIS
Presence & Recognition
EATRIS is hosting a webinar on 19 October titled INFRAFRONTIER to explore five advanced in vitro approaches spanning infection, cancer, neurological disease, and muscle pathology.
Reported by EATRIS
Presence & Recognition
EATRIS Türkiye National Director Dr Özlem Yalçın Seyhan will speak at the EOSC Symposium 14-16 October 2026 in Florence.
Reported by EATRIS
Partnerships
EATRIS, SHARE-ERIC, and academic partners developed ONCOLIGHT – Systems Learning for Equitable Cancer Care following an EATRIS-CONNECT event on ageing hosted by the University of Zagreb School of Medicine.
Reported by EATRIS
Presence & Recognition
EATRIS is hosting the REMEDi4ALL Patient Bootcamp in Barcelona on 10-11 June 2027 to advance expertise in drug repurposing.
Reported by EATRIS
Presence & Recognition
EATRIS is participating in the ERDERA Clinical Trial Call to support multinational, GCP-compliant early-phase interventional clinical trials in rare diseases.
Reported by EATRIS
Presence & Recognition
EATRIS Scientific Lead AI for Medical Applications Sara Zullino shared updates on the EUCAIM project in a recent video.
Reported by EATRIS
Presence & Recognition
EATRIS announced that an academic researcher and Venture Builder will present insights on pitching early-stage projects to potential funders at the Public-Private Collaboration Accelerator webinar on 16 September 2026.
Reported by EATRIS